Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health
View Image
The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma - Radiotherapy and Oncology
Event-free survival > Overall survival? - data analysis - Datamethods Discussion Forum
図11 Overall Survival (Updated)
![Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2022/12646/1/fig-2-full.png "Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma [PeerJ]")
Identification and validation of an epithelial mesenchymal transition-related gene pairs signature for prediction of overall survival in patients with skin cutaneous melanoma [PeerJ]
JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG
Overall Survival Curve [IMAGE] | EurekAlert! Science News Releases
Progression free survival rate at 9 and 18weeks predict overall survival in patients with malignant pleural mesothelioma: An individual patient pooled analysis of 10 European Organisation for Research and Treatment of Cancer
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
Overall survival plot. Kaplan–Meier curve is shown for overall survival... | Download Scientific Diagram
Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell
Overall survival for oncology drugs approved for genomic indications - European Journal of Cancer
Overall survival of stage IV non-small cell lung cancer patients treated with Viscum album L. in addition to chemotherapy, a real-world observational multicenter analysis | PLOS ONE
Overall Survival. Kaplan-Meier estimates of overall survival in... | Download Scientific Diagram
Overall survival with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive, HER2-negative metastatic breast cancer in the PEARL study - European Journal of Cancer
Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC - Journal of Hepatology
Correlation of Prostate-specific Antigen Kinetics with Overall Survival and Radiological Progression-free Survival in Metastatic Castration-sensitive Prostate Cancer Treated with Abiraterone Acetate plus Prednisone or Placebos Added to Androgen ...
図14 Overall Survival
